Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8520114 | 0.88 | GBA1 (0.39) | SMN1; SMN2MEN1KMT2AALDH1A1CYP19A1 | |
| SCHEMBL21389463 | 0.81 | ALDH1A1 (0.31) | MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL21389465 | 0.81 | ALDH1A1 (0.31) | MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL24796036 | 0.81 | ALDH1A1 (0.31) | MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL21389325 | 0.81 | USP2 (0.38) | MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL5692758 | 0.77 | USP2 (0.33) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL24796420 | 0.76 | KDM4E (0.32) | ALDH1A1KDM4E | |
| SCHEMBL21389322 | 0.76 | KDM4E (0.32) | ALDH1A1KDM4E | |
| SCHEMBL21389504 | 0.76 | KDM4E (0.32) | ALDH1A1KDM4E | |
| SCHEMBL14629445 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019183577-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. (US) | 2019-09-26 | — | — | WO | disclosed |